英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
mousquetaire查看　mousquetaire　在百度字典中的解释百度英翻中〔查看〕
mousquetaire查看　mousquetaire　在Google字典中的解释Google英翻中〔查看〕
mousquetaire查看　mousquetaire　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • ENJAYMO® (sutimlimab-jome) | Cold Agglutinin Disease Treatment
    ENJAYMO is the first and only FDA-approved treatment for people with cold agglutinin disease (CAD) to help decrease the need for red blood cell transfusion
  • Sutimlimab - Wikipedia
    Sutimlimab, sold under the brand name Enjaymo, is a monoclonal antibody that is used to treat adults with cold agglutinin disease (CAD) [1][3][4] It is given by intravenous infusion [1] Sutimlimab prevents complement-enhanced activation of autoimmune human B cells in vitro [5] The most common side effects include headache, high blood pressure, urinary tract infection (infection of the
  • Enjaymo: Uses, Dosage, Side Effects Warnings - Drugs. com
    Enjaymo (sutimlimab-jome) is used in the treatment cold agglutinin disease (CAD) Includes Enjaymo side effects, interactions and indications
  • LABEL - accessdata. fda. gov
    ENJAYMO solution is a clear to slightly opalescent and colorless to slightly yellow liquid Do not administer if discolored or if other foreign particulate matter is present Withdraw the calculated volume of ENJAYMO from the appropriate number of vials based on the recommended dosage (see Table 1) and add to an empty infusion bag
  • ENJAYMO® (sutimlimab-jome) | Healthcare Professional Website
    ENJAYMO, a proximal classical complement C1s inhibitor, increases susceptibility to serious infections, including those caused by encapsulated bacteria e g Neisseria meningitidis (any serogroup, including non-groupable strains), Streptococcus pneumoniae, and Haemophilus influenzae type B
  • Enjaymo - European Medicines Agency (EMA)
    Overview Enjaymo is a medicine for treating haemolytic anaemia (excess breakdown of red blood cells) in adults with cold agglutinin disease (CAD) CAD is a rare blood disorder where the immune system (the body’s natural defence) recognises red blood cells as foreign and attacks them This causes agglutination (clumping together) and haemolysis (disruption) of the red blood cells, resulting
  • Enjaymo (sutimlimab): Uses, Side Effects, Dosage Reviews
    Enjaymo (sutimlimab or sutimlimab-jome) is a newly-approved medication used to lower the need for blood transfusions in adults with a rare form of anemia called cold agglutinin disease (CAD) It's given as an infusion into the veins by a healthcare provider
  • HIGHLIGHTS OF PRESCRIBING INFORMATION . . .
    HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ENJAYMO safely and effectively See full prescribing information for ENJAYMO ENJAYMO® (sutimlimab-jome) injection, for intravenous use Initial U S Approval: 2022
  • Enjaymo: Uses, Dosage, Side Effects Warnings - en
    Enjaymo is a prescription medicine that affects your immune system Enjaymo can lower the ability of your immune system to fight infections People who take Enjaymo may have an increased risk of getting infections caused by certain kinds of bacteria such as Neisseria meningitides, Streptococcus pneumoniae, and Haemophilus influenzae
  • ENJAYMO® (sutimlimab-jome) | What is ENJAYMO?
    ENJAYMO is a chemotherapy-free treatment proven to help stop the destruction of red blood cells (hemolysis) in cold agglutinin disease (CAD)





中文字典-英文字典  2005-2009